. . . . . . . . . . . "a(CHEBI:troglitazone) -| path(SDIS:\"tumor growth\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "TGZ inhibits the clonogenic growth of at least half of the breast cancer cell lines tested and induces apoptosis, if combined with a ligand for RXR (LG10069), RAR (ATRA), or both (9cRA) TGZ or Wy-14,643 was as effective as tamoxifen in preventing additional tumor development. Wy-14,643 can even reduce the development of mammary tumors when administered prior to detection." . . "Selventa" . . . . "2014-07-03T14:30:17.930+02:00"^^ . . .